Ascendis Pharma A ASND
NASDAQ ASND
$227.87 +0.56 (+0.25%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Other Accumulated Expenses (2017 - 2026)

Updated

Ascendis Pharma A's Other Accumulated Expenses came in at $540.37 million for the quarter ended Jun 30, 2026, up 44.5% from $373.94 million a year earlier and up 18.9% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Other Accumulated Expenses (2017 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A's Other Accumulated Expenses was $433.59 million.

  • Other Accumulated Expenses carries a five-year compound annual growth rate of 68.9% (years ended Dec 2020 to Dec 2025).
  • Going back by year, Other Accumulated Expenses was $36.07 million in the year ended Dec 31, 2024 (-82.1%), $201.33 million in the year ended Dec 31, 2023 and $34.26 million in the year ended Dec 31, 2021 (+8.7%).
  • The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Other Accumulated Expenses in data going back to the quarter ended Dec 31, 2017.
  • Year-over-year, Other Accumulated Expenses increased in five of the last six quarters, with growth averaging 24.4%.
  • The fastest year-over-year change in Other Accumulated Expenses over five years came in the quarter ended Sep 30, 2021 (growth of 67.1%), and the weakest in the quarter ended Dec 31, 2024 (a decline of 82.2%).
  • Business Quant data shows ASND's Other Accumulated Expenses at $454.37 million (quarter ended Mar 31, 2026), $446.72 million (quarter ended Dec 31, 2025) and $381.68 million (quarter ended Sep 30, 2025) in the three quarters before the quarter ended Jun 30, 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 540.37 Mn
Mar 31, 2026 454.37 Mn
Dec 31, 2025 446.72 Mn
Sep 30, 2025 381.68 Mn
Jun 30, 2025 373.94 Mn
Mar 31, 2025 274.93 Mn
Dec 31, 2024 35.62 Mn
Sep 30, 2024 272.41 Mn
Jun 30, 2024 276.21 Mn
Mar 31, 2024 191.96 Mn
Dec 31, 2023 200.25 Mn
Dec 31, 2021 34.26 Mn
Sep 30, 2021 38.16 Mn
Jun 30, 2021 22.43 Mn
Mar 31, 2021 13.57 Mn
Dec 31, 2020 31.53 Mn
Sep 30, 2020 22.83 Mn
Jun 30, 2020 17.87 Mn
Mar 31, 2020 8.48 Mn
Dec 31, 2019 16.88 Mn
API Access

Ascendis Pharma A Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ASND&period=max&api_key=YOUR_API_KEY